NCT03895086

Brief Summary

Fibromyalgia is a common, expensive and controversial condition, one of whose origins would be central nervous system sensitization to pain. Usual treatment consists of multimodal care including physical activity. This dosage should be adapted to the patient's health needs. Currently recommended physical exercise is aerobic work associated with muscle reinforcement, without evidence of superiority of the efficacy of one over the other. Recommended dosage for aerobic exercises is 20 minutes (or twice 10 minutes), two to three times a week (70 - 80% of Theoretical Maximum Heart Rate). At the Vendee Departmental Hospital Center (CHD), adapted physical activity is proposed to fibromyalgia patientsby the associative group "Siel Bleu". This physical activity, performed with patients suffering from different pathologies, is non specific for fibromyalgia context. In parallel, a preliminary study showed the interest of a lifestyle coaching for fibromyalgia patients, performed by physiotherapists, nurses and coaches specifically trainede. Another possibility seems to be personalized coaching with a physical activity adapted to the physical and organizational constraints of the patient, and specific to pathology. This solution would make it possible to adapt to the patient's choice of physical activities, to ensure a better adaptation to their physical and organizational constraints as well as a better individualized follow-up.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 29, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

February 13, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2021

Completed
3.7 years until next milestone

Results Posted

Study results publicly available

September 23, 2024

Completed
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

March 28, 2019

Results QC Date

June 15, 2023

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare the Interest of a Specific Physical Activity Program on Patients' Quality of Life

    Evolution of the Fibromyalgia Impact Questionnaire (FIQ) score (questionnaire of specific quality of life in the management of fibromyalgia patients) between the beginning of care (J0) and six months (M6). The scale score ranges from 0 to 100. The higher the score, the greater the difficulty in functioning and the severity of symptoms.

    6 months after randomization

Study Arms (2)

Specific Physical Activity

EXPERIMENTAL

Specific patient care in telephone coaching of fibromyalgia patients.

Other: Specific Physical Activity

Classic Physical Activity

OTHER

Classic patient care in common group of multipathological patients.

Behavioral: Classic Physical Activity

Interventions

An individual one hour face-to-face session conducted by adaptated physical activities teachers followed by eight telephone sessions by physical therapists and adaptated physical activities teachers (4 sessions each)

Specific Physical Activity

One session per week in groups conducted by adaptated physical activities teachers of "Siel Bleu" association

Classic Physical Activity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Major patient
  • Patient whose FIQ ≤ 59/100
  • Patient who can be followed for 12 months in the CETD
  • Patient able to follow the adaptated physical activities proposed by "Siel Bleu", on the physical and organizational level
  • Patient with a smartphone and/or a computer (mac/pc) with an internet connection allowing the use of a tracking application linked to the activity tracker
  • Patient with the ability to understand protocol and consenting to participate in this study
  • Patient benefiting from a social cover

You may not qualify if:

  • Patient participating in an interventional trial within 3 months of enrollment
  • Pregnant or lactating woman, or having the possibility to procreate without effective contraception
  • Patient minor, under guardianship, curators or deprived of liberty
  • Patient unable to follow the protocol, according to the judgment of the investigator, or refusing to use of digital applications
  • Patient with contraindications to physical activity
  • Patient having already followed the physical activities proposed by 'Siel Bleu"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Départemental Vendée

La Roche-sur-Yon, France

Location

Centre Hospitalier Universitaire

Nantes, France

Location

Related Publications (1)

  • Rulleau T, Planche L, Etcheverrigaray F, Dorion A, Kacki N, Miot M, Liaigre A, Ganem Y, Schmidt A, Taddei F, Acapo S, Nizard J, Pluchon YM. Comparison of patient-led, fibromyalgia-orientated physical activity and a non-specific, standardised 6-month physical activity program on quality of life in individuals with fibromyalgia: a protocol for a randomised controlled trial. Trials. 2020 Sep 17;21(1):800. doi: 10.1186/s13063-020-04730-3.

    PMID: 32943085BACKGROUND

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Results Point of Contact

Title
Mr Thomas RULLEAU
Organization
Maison de la Recherche en Santé

Study Officials

  • Thomas RULLEAU

    CHD Vendée

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2019

First Posted

March 29, 2019

Study Start

February 13, 2020

Primary Completion

January 14, 2021

Study Completion

January 14, 2021

Last Updated

April 23, 2026

Results First Posted

September 23, 2024

Record last verified: 2026-04

Locations